For the best experience on the Abcam website please upgrade to a modern browser such as
Mouse monoclonal [2H2] to EGFL7
Recombinant fusion protein (Human)- His tagged
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
Constituents: 0.75% Glycine, 1.21% Tris, 2% Sucrose
Concentration information loading...
Protein A purified
Light chain type
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/200 - 1/1000. Predicted molecular weight: 30 kDa.
1/100 - 1/500.
Regulates vascular tubulogenesis in vivo. Inhibits platelet-derived growth factor (PDGF)-BB-induced smooth muscle cell migration and promotes endothelial cells adhesion to the substrate in vitro.
Contains 2 EGF-like domains.
Contains 1 EMI domain.
Information by UniProt
EGF like domain 7 antibody
EGF like domain containing protein 7 antibody
EGF like domain multiple 7 antibody
This product has been referenced in:
et al. High expression of epidermal growth factor-like domain 7 is correlated with poor differentiation and poor prognosis in patients with epithelial ovarian cancer. J Gynecol Oncol 25:334-41 (2014).
Read more (PubMed: 25142627) »
et al. Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis. Arthritis Res Ther 15:R165 (2013).
Read more (PubMed: 24286167) »
See all 3 Publications
for this product
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"